Progression to insulin deficiency in Korean patients with Type 2 diabetes mellitus positive for anti-GAD antibody.

Lee, S A; Lee, W J; Kim, E H; Yu, J H; Jung, C H; Koh, E H; Kim, M-S; Park, J-Y; Lee, K-U
Diabetic medicine : a journal of the British Diabetic Association
2011Mar ; 28 ( 3 ) :319-24.
ÀúÀÚ »ó¼¼Á¤º¸
Lee, S A -
Lee, W J -
Kim, E H -
Yu, J H -
Jung, C H -
Koh, E H -
Kim, M-S -
Park, J-Y -
Lee, K-U -
ABSTRACT
AIMS: To investigate the rate of progression to insulin deficiency in Korean patients with Type 2 diabetes mellitus positive for anti-GAD antibody (GADA) and to determine the factors related to progression to insulin deficiency.

METHODS: We retrospectively analysed data on 87 GADA-positive and 87 age- and sex-matched GADA-negative patients with Type 2 diabetes. GADA-positive patients were further subclassified into high-titre (??250 WHO units/ml) (n = 24) and low-titre (< 250 WHO units/ml) (n = 63) subgroups. Cox proportional hazard analysis was used to identify factors associated with progression to insulin deficiency.

RESULTS: Over a period of 6 years, two of 87 (2.3%) GADA-negative and 37 of 87 (42.5%) GADA-positive patients had progressed to insulin deficiency. The rate of progression to insulin deficiency was higher in the high-titre than in the low-titre subgroup (75.0 vs. 30.2%). Multivariate analysis in GADA-positive patients showed that high-titre GADA and low BMI at diagnosis were independent factors significantly related to progression to insulin deficiency.

CONCLUSIONS: The presence of GADA predicted the progression to insulin deficiency in Korean patients with Type 2 diabetes. In GADA-positive patients, high-titre GADA and low BMI were associated with this progression. CI - ??2011 The Authors. Diabetic Medicine ??2011 Diabetes UK.
anti-GAD antibody, C-peptide, insulin deficiency, Type 2 diabetes mellitus
MESH
*Asian Continental Ancestry Group, Autoantibodies/*analysis, Diabetes Mellitus, Type 1/blood/*immunology/physiopathology, Diabetes Mellitus, Type 2/blood/*immunology/physiopathology, Disease Progression, Female, Humans, Islets of Langerhans/*immunology, Male, Middle Aged, Proportional Hazards Models, Retrospective Studies
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This study reported that 42.5% of GADA-positive patients with Type 2diabe tes progressed to insulin deficiency over 6 years comparedwith 2.3% of GADA-negative patients.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1111/j.1464-5491.2010.03186.x
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå